Doctor profile · Federal record
Dr. JASBIR DHAWAN, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · FRISCO, TX
- NPI 1063458230
- Accepts Medicare
- MIPS 86.1 / 100 · 2023
- 39 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
14725 LEBANON ROAD, SUITE 100
FRISCO, TX 75035
(214) 705-9000
fax (214) 619-5675
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- January 5, 2015
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Texas #N0729 · Missouri #2001010856
- Medicaid (3)
- KS #100413460B · MO #2087666303 · OK #100053530A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063458230. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
30,137
Distinct HCPCS
10
Medicare allowed
$627,039
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 17,640 | 20 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 10,380 | 109 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,030 | 457 | $123 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 410 | 137 | $33 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 259 | 127 | $70 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 167 | 93 | $173 | |
90674 |
Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 72 | 72 | $33 | |
G0008 |
Administration of influenza virus vaccine | 72 | 72 | $30 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 61 | 61 | $213 | |
95250 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 35 | 27 | $139 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,739. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$8,277
Transactions
140
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 14 | $4,968.66 | |
| Tandem Diabetes Care, Inc. | 3 | $825.84 | |
| Lilly USA, LLC | 22 | $326.22 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $308.01 | |
| Mannkind Corporation | 20 | $239.69 | |
| Abbott Laboratories | 12 | $186.62 | |
| Currax Pharmaceuticals LLC | 15 | $161.74 | |
| Amgen Inc. | 9 | $148.28 | |
| Corcept Therapeutics | 6 | $133.06 | |
| Antares Pharma, Inc. | 6 | $130.32 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114.11 | |
| SANOFI-AVENTIS U.S. LLC | 5 | $102.09 | |
| Amneal Pharmaceuticals LLC | 4 | $85.79 | |
| Radius Health, Inc. | 4 | $79.00 | |
| Dexcom, Inc. | 3 | $67.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,726
Patients
736
Total drug cost
$1,013,879
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 258 | 84 | $380,836 |
| Levothyroxine Sodium | Generic | 189 | 92 | $3,551 |
| Jardiance (Empagliflozin) | Brand | 157 | 63 | $151,437 |
| Trulicity (Dulaglutide) | Brand | 131 | 45 | $204,659 |
| Atorvastatin Calcium | Generic | 129 | 71 | $1,672 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 122 | 42 | $122,612 |
| Metformin Hcl | Generic | 114 | 63 | $1,000 |
| Synthroid (Levothyroxine Sodium) | Brand | 107 | 50 | $14,081 |
| Synjardy Xr (Empagliflozin/Metformin Hcl) | Brand | 87 | 32 | $72,926 |
| Unithroid (Levothyroxine Sodium) | Brand | 87 | 37 | $2,721 |